Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
31,054,676
-
Share change
-
+162,426
-
Total reported value
-
$251,838,548
-
Put/Call ratio
-
61%
-
Price per share
-
$8.11
-
Number of holders
-
101
-
Value change
-
-$43,450,033
-
Number of buys
-
55
-
Number of sells
-
54
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2015
As of 30 Sep 2015,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,054,676 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, WASATCH ADVISORS INC, JPMORGAN CHASE & CO, SCOPIA CAPITAL MANAGEMENT LP, JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, EverPoint Asset Management, LLC, and BlackRock Fund Advisors.
This page lists
101
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.